StockData

GE HealthCare Technologies vs Medtronic

GEHC and MDT side by side, both in surgical, medical, and dental instruments and supplies. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How GEHC and MDT compare

Medtronic is the larger company, worth 3.5 times as much as GE HealthCare Technologies ($131B against $37.0B).

On earnings, GE HealthCare Technologies is cheaper: it trades at 17.3× trailing earnings, against 25.1× for Medtronic.

Medtronic grew revenue faster over the last twelve months (9.8% versus 6.9% for GE HealthCare Technologies).

Medtronic keeps more of each dollar of sales as profit, with a net margin of 13.9% compared with 10.0% at GE HealthCare Technologies.

Both pay dividends: GE HealthCare Technologies yields 0.18% and Medtronic 2.8%.

Medtronic scores higher on the StockData Score (18 against 15 for GE HealthCare Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricGEHCMDT
Size and price
Market cap$37.0B$131B
Share price$81.84$102.32
Change, 1 year11.9%6.7%
Change, 5 years–−7.9%
Beta (5Y)0.56−0.24
Employees54K95K
StockData Score
Total score1518 (better)
Valuation score5 (better)4
Growth score12 (better)
Performance score44
Health score24 (better)
Dividend score34 (better)
Valuation
P/E17.3× (better)25.1×
P/S1.7× (better)3.5×
P/B3.2×2.6× (better)
EV/EBITDA15.3× (better)15.5×
P/FCF19.6× (better)21.3×
PEG6.792.57 (better)
FCF yield5.1% (better)4.7%
Fair value$92.13$99.63
Margin of safety11.2% (better)−2.7%
Growth
Revenue growth (TTM)6.9%9.8% (better)
Revenue growth, 5Y average–3.8%
Net income growth (TTM)−2.8%12.3% (better)
EPS growth (TTM)−2.1%12.1% (better)
EPS growth, 5Y average–7.0%
Profitability
Gross margin39.9%65.0% (better)
Operating margin13.3%18.1% (better)
Net margin10.0%13.9% (better)
FCF margin8.7%16.3% (better)
Return on equity19.9% (better)10.7%
Return on invested capital12.4% (better)7.9%
Financial health
Debt / equity0.860.56 (better)
Net debt / EBITDA2.481.99 (better)
Interest coverage–9.4×
Current ratio1.302.07 (better)
Altman Z-score1.983.15 (better)
Piotroski F-score57 (better)
Dividends and buybacks
Dividend yield0.18%2.8% (better)
Payout ratio3.0%69.8%
Years of dividend growth213 (better)
Dividend growth, 5Y average–4.1%
Buyback yield0.81%0.90% (better)
Shareholder yield0.99%3.7% (better)
Ownership
Held by institutions87.2%86.5%
Held by insiders0.33%0.09%
Insider net buying, 12 months$6.4M (better)−$11.6M
Superinvestors holding5–
Short interest, % of float4.1%1.8%

Go deeper

Other comparisons

For information only, not investment advice. Check the source filings before relying on any figure.